March 8, 2010 – Cardiovascular death is the most common cause of mortality among type 2 diabetics and claims the lives of millions each year, with many diabetics experiencing their first “symptom” as a heart attack or sudden death. Understanding that diabetics are at high risk for coronary heart disease (CHD) and many are asymptomatic, Toshiba America Medical Systems Inc.

March 9, 2010 — An analysis of six tests that are used to measure platelet function and help gauge the effectiveness of antiplatelet drugs for patients undergoing a cardiac procedure such as a coronary stent implantation found that only three of the tests were associated with a modest ability to predict outcomes such as heart attack or death, according to a study in the Feb.

March 2, 2010 — Leg arteries that become narrow decrease blood circulation and can cause these extremities to ache or cramp when a person begins exercise. This condition is referred to as intermittent claudication (IC). Although the pain may subside with rest, IC should be taken seriously because it can increase the risk of heart attack and stroke.

March 8, 2010 – Advanced visualization and decision support solutions maker TeraRecon was awarded Frost and Sullivan’s “Company of the Year Award,” in the category of medical imaging, advanced visualization applications, Europe 2010. This award represents the fifth time TeraRecon has been recognized with an award from the healthcare market-consulting firm.

March 8, 2010 – Bifurcation stent developer Tryton Medical Inc. recently announced its Tryton stent implants reached a milestone of 750 patients and recently had its first implants in Portugal and Austria.